Ontology highlight
ABSTRACT: Type II JAK2 Inhibitor NVP-CHZ868 is Active in Vitro and in Vivo Against JAK2-Dependent B-cell Acute Lymphoblastic Leukemias
PROVIDER: PRJNA261873 | ENA |
REPOSITORIES: ENA
ACCESS DATA
